Search Results - "Korotaeva, Tatiana V."

Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations by Leung, Ying-Ying, Korotaeva, Tatiana V, Candia, Liliana, Pedersen, Susanne Juhl, Bautista Molano, Wilson, Ruderman, Eric M, Bisoendial, Radjesh, Perez-Alamino, Rodolfo, Olsder, Wendy, Möller, Burkhard, Grazio, Simeon, Gudu, Tania, Mody, Girish M, Pineda, Carlos, Raffayova, Helena, Rohekar, Sherry, Goldenstein-Schainberg, Claudia, Gutierrez Urena, Sergio R, Casasola Vargas, Julio César, Meghnathi, Bhowmik, Prasad, Roopa, Richette, Pascal, Miranda, Jose Roberto S, Malliotis, Nikolas, Lindqvist, Ulla, Simon, David, Ezeonyeji, Amara, Soriano, Enrique R, FitzGerald, Oliver

“…We aimed to compile evidence for the efficacy and safety of therapeutic options for the peripheral arthritis domain of psoriatic arthritis (PsA) for the…”
Get full text

Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study by Gossec, Laure, Siebert, Stefan, Bergmans, Paul, de Vlam, Kurt, Gremese, Elisa, Joven-Ibáñez, Beatríz, Korotaeva, Tatiana V, Lavie, Frederic, Noël, Wim, Nurmohamed, Michael T, Sfikakis, Petros P, Sharaf, Mohamed, Theander, Elke, Smolen, Josef S

“…To evaluate the real-world effect of the IL-12/23 inhibitor ustekinumab or of a tumour necrosis factor inhibitor (TNFi) on patient-reported outcomes (PRO) and…”
Get full text

TCR repertoire profiling revealed antigen-driven CD8+ T cell clonal groups shared in synovial fluid of patients with spondyloarthritis by Komech, Ekaterina A., Koltakova, Anastasia D., Barinova, Anna A., Minervina, Anastasia A., Salnikova, Maria A., Shmidt, Evgeniya I., Korotaeva, Tatiana V., Loginova, Elena Y., Erdes, Shandor F., Bogdanova, Ekaterina A., Shugay, Mikhail, Lukyanov, Sergey, Lebedev, Yury B., Zvyagin, Ivan V.

“…Spondyloarthritis (SpA) comprises a number of inflammatory rheumatic diseases with overlapping clinical manifestations. Strong association with several HLA-I…”
Get full text

Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis by Chamurlieva, Maria N., Korsakova, Yulia L., Radenska-Lopovok, Stefka G., Korotaeva, Tatiana V.

“…Biological disease-modifying anti-rheumatic drugs (bDMARDs) are widely used for the treatment of chronic inflammatory rheumatic diseases. Since the…”
Get full text

A new integral enthesial-comorbididity index of psoriatic arthritis activity by Korsakova, Y L, Korotaeva, T V, Loginova, E Y, Gubar, E E, Vorobyeva, L D, Glukhova, S I, Nasonov, E L

“…To develop an integral index of psoriatic arthritis (PsA) activity. 117 patients with PsA (M/F - 63/54) were included. Patients' age 44±11 years, psoriasis…”
Get full text

The burden of progression of psoriatic arthritis. All-Russian register data by Korsakova, Yulia L., Loginova, Elena Yu, Korotaeva, Tatiana V., Gubar, Elena E., Glukhova, Svetlana I., Vasilenko, Elizaveta A., Nasonov, Evgeny L.

“…Background. Psoriatic arthritis (PsA) is a complex immune-mediated disease in which a third of patients with psoriasis (PsO) have a inflammatory lesion of both…”
Get full text

The relationship between obesity, cardiometabolic disorders and disease activity in psoriatic arthritis patients: data from the Russian register by Korsakova, Yuliia L., Korotaeva, Tatiana V., Loginova, Elena I., Gubar, Elena E., Vasilenko, Elizaveta A., Vasilenko, Aleksei A., Kuznetsova, Natalia A., Patrikeeva, Irina M., Nasonov, Evgeny L.

“…Aim. To study the relationship between obesity, cardiometabolic disorders and disease activity in patients with psoriatic arthritis (PsA) in real practice…”
Get full text

O24 Concomitant treatment with MTX does not increase the efficacy of ustekinumab or TFNi in PsA: results from the PsABio study by Siebert, Stefan, Gremese, Elisa, Bergmans, Paul, de Vlam, Kurt, Joven-Ibáñez, Beatriz, Katsifis, Gkikas, Korotaeva, Tatiana V, Noël, Wim, Selmi, Carlo, Sfikakis, Petros P, Smirnov, Pavel, Theander, Elke, Nurmohamed, Michael T, Gossec, Laure, Smolen, Josef S

“…Abstract Background The additional benefit of methotrexate (MTX) as a concomitant treatment in PsA has not been fully elucidated for TNF inhibitors (TNFi) and…”
Get full text

Clinical and instrumental characteristics of psoriatic arthritis in men and women. Data from a cohort observational study by Korsakova, Y L, Korotaeva, T V, Loginova, E I, Gubar, E E, Petrov, A V, Patrikeeva, I M, Umnova, I F, Sorotskaya, V N, Pristavskii, I N, Sedunova, M V, Nasonov, E L

“…To study and compare the clinical and imaging characteristics of psoriatic arthritis (PsA) in men and women. The study included 956 PsA patients observed in…”
Get full text

Characteristics of patients with psoriatic arthritis treated with ustekinumab. Evidence from real-life clinical practice by Korsakova, Yu. L., Loginova, E. Yu, Gubar, E. E., Korotaeva, T. V.

“…Introduction . Psoriatic arthritis (PsA) is a chronic immunoinflammatory disease characterised by involvement of the skin, nail plates, joints, spine and…”
Get full text

Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha in Patients with Early Psoriatic Arthritis by Markelova, E. I., Novikova, D. S., Korotaeva, T. V., Loginova, E. Yu

“…Background. Patients with psoriatic arthritis (PsA) have increased risk of cardiovascular diseases (CVD). Anti-tumor necrosis factor (TNF) therapy is an…”
Get full text

Netakimab in anti-tnF-naïve patients with psoriatic arthritis: subanalysis of patEra clinical trial by Korotaeva, Tatiana V., Samtsov, Aleksei V., Khairutdinov, Vladislav R., Bakulev, Andrei L., Mladov, Vladimir V., Eremeeva, Anna V., Zinkina-Orikhan, Arina V.

“…Нетакимаб (НТК) – гуманизированное моноклональное антитело против интерлейкина-17А. Препарат зарегистрирован для лечения псориатического артрита (ПсА),…”
Get full text

Cardiovascular Risk in Psoriatic Arthritis: Search for New Biological Markers by Korotaeva, Tatiana V., Loginova, Elena Yu, Novikova, Diana S., Klimova, Nadezhda V., Novikov, Aleksandr A., Denisov, Lev N., Firsov, Nikolay N., Erdes, Shandor

“…Objective We investigated the relationships between the risk for coronary heart disease (CHD), psoriatic arthritis activity, and red blood cell aggregation…”
Get full text